The clinical significance of plasma clusterin and Aβ in the longitudinal follow-up of patients with Alzheimer’s disease
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The clinical significance of plasma clusterin and Aβ in the longitudinal follow-up of patients with Alzheimer’s disease
Authors
Keywords
Clusterin, Alzheimer’s disease, Predictor, Progression
Journal
Alzheimers Research & Therapy
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-11-23
DOI
10.1186/s13195-017-0319-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition
- (2017) Jong-Chan Park et al. Alzheimers Research & Therapy
- Plasma Amyloid-β as a Biomarker in Alzheimer's Disease: The AIBL Study of Aging
- (2017) James K. Lui et al. JOURNAL OF ALZHEIMERS DISEASE
- The Relationship Between Plasma Aβ Levels, Cognitive Function and Brain Volumetrics: Sydney Memory and Ageing Study
- (2016) Anne Poljak et al. Current Alzheimer Research
- Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer’s Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects
- (2016) Louis De Beaumont et al. JOURNAL OF ALZHEIMERS DISEASE
- Risk Factors Associated With Cognitive, Functional, and Behavioral Trajectories of Newly Diagnosed Dementia Patients
- (2016) Eric Jutkowitz et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin
- (2016) Yuetiva Deming et al. NEUROBIOLOGY OF AGING
- Plasma β-amyloid in Alzheimer’s disease and vascular disease
- (2016) Shorena Janelidze et al. Scientific Reports
- Longitudinal plasma amyloid beta in Alzheimer's disease clinical trials
- (2015) Michael C. Donohue et al. Alzheimers & Dementia
- Risk Factors for Progression of Alzheimer Disease in a Canadian Population: The Canadian Outcomes Study in Dementia (COSID)
- (2015) Nathan Herrmann et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- The Course of Neuropsychiatric Symptoms in Dementia: A 3-Year Longitudinal Study
- (2015) Henry Brodaty et al. Journal of the American Medical Directors Association
- Plasma Clusterin and Lipid Profile: A Link with Aging and Cardiovascular Diseases in a Population with a Consistent Number of Centenarians
- (2015) Angela Baralla et al. PLoS One
- Plasma and platelet clusterin ratio is altered in Alzheimer's disease patients with distinct neuropsychiatric symptoms: findings from a pilot study
- (2014) Elizabeta B. Mukaetova-Ladinska et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- ABCA7 gene and the risk of Alzheimer's disease in Han Chinese in Taiwan
- (2014) Yi-Chu Liao et al. NEUROBIOLOGY OF AGING
- The future of blood-based biomarkers for Alzheimer's disease
- (2013) Kim Henriksen et al. Alzheimers & Dementia
- Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease
- (2013) Alan Rembach et al. Alzheimers & Dementia
- Subscale Validation of the Neuropsychiatric Inventory Questionnaire: Comparison of Alzheimer's Disease Neuroimaging Initiative and National Alzheimer's Coordinating Center Cohorts
- (2013) Paula T. Trzepacz et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Fluid Biomarkers in Alzheimer Disease
- (2013) K. Blennow et al. Cold Spring Harbor Perspectives in Medicine
- The Demographic and Medical Correlates of Plasma Aβ40 and Aβ42
- (2012) Andrea L. Metti et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Improved protocol for measurement of plasma β-amyloid in longitudinal evaluation of Alzheimer’s Disease Neuroimaging Initiative study patients
- (2012) Michal J. Figurski et al. Alzheimers & Dementia
- Potential Blood Biomarker for Disease Severity in the Taiwanese Population With Alzheimer’s Disease
- (2012) Ching-Wen Huang et al. American Journal of Alzheimers Disease and Other Dementias
- Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairment
- (2012) I. H. G. B. Ramakers et al. PSYCHOLOGICAL MEDICINE
- Apolipoprotein E Polymorphism and Behavioral and Psychological Symptoms of Dementia in Patients With Alzheimer Disease
- (2011) Cheng-Sheng Chen et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- Plasma Clusterin and the Risk of Alzheimer Disease
- (2011) Elisabeth M. C. Schrijvers JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Blood-based biomarkers for Alzheimer's disease: plasma Aβ40 and Aβ42, and genetic variants
- (2011) Richard Mayeux et al. NEUROBIOLOGY OF AGING
- Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment
- (2011) Madhav Thambisetty et al. NEUROIMAGE
- Autism, Alzheimer disease, and fragile X: APP, FMRP, and mGluR5 are molecular links
- (2011) D. K. Sokol et al. NEUROLOGY
- Predicting cognitive decline in Alzheimer's disease: An integrated analysis
- (2010) Oscar L. Lopez et al. Alzheimers & Dementia
- Progression of Cognitive, Functional, and Neuropsychiatric Symptom Domains in a Population Cohort With Alzheimer Dementia: The Cache County Dementia Progression Study
- (2010) JoAnn T. Tschanz et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Association of Plasma Clusterin Concentration With Severity, Pathology, and Progression in Alzheimer Disease
- (2010) Madhav Thambisetty et al. ARCHIVES OF GENERAL PSYCHIATRY
- Plasma β-Amyloid and Cognitive Decline
- (2010) Stephanie A. Cosentino et al. ARCHIVES OF NEUROLOGY
- Clusterin: A forgotten player in Alzheimer's disease
- (2009) Tapio Nuutinen et al. BRAIN RESEARCH REVIEWS
- Amyloid β peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing
- (2009) P. Lewczuk et al. EXPERIMENTAL NEUROLOGY
- Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
- (2009) Jean-Charles Lambert et al. NATURE GENETICS
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
- (2009) Denise Harold et al. NATURE GENETICS
- Early Frontal Executive Impairment as a Predictor of Subsequent Behavior Disturbance in Dementia
- (2008) Tung Tsoi et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Structural and Quantitative Comparison of Cerebrospinal Fluid Glycoproteins in Alzheimer’s Disease Patients and Healthy Individuals
- (2008) Carina Sihlbom et al. NEUROCHEMICAL RESEARCH
- Effects of medications on plasma amyloid beta (Aβ) 42: Longitudinal data from the VITA cohort
- (2007) Imrich Blasko et al. JOURNAL OF PSYCHIATRIC RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started